Cell viability assays showed that the sensitivity of BLCA cells was decreased when ENO1 was overexpressed (Supplementary Fig. S5C), and the reduced clone number via melatonin treatment was also rescued when ENO1 was overexpressed (Supplementary Fig. S5E). Here, ENO1 is linked to bladder transitional cell carcinoma.